CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial Why and How to Measure Aortic Valve Calcification in Patients With Aortic Stenosis Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)

Clinical Trial2012 Jan 24;125(3):505-13.

JOURNAL:Circulation. Article Link

Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study

Gwon HC, Hahn JY, Kim HS et al. Keywords: DAPT duration; coronary artery disease; DES; platelet aggregation; inhibitors; stents; thrombosis

FULL TEXT PDF